Advertisement

Canadian Journal of Public Health

, Volume 97, Issue 3, pp 241–247 | Cite as

Rationale and Implementation of the SLICK Project

Screening for Limb, I-Eye, Cardiovascular and Kidney (SLICK) Complications in Individuals with Type 2 Diabetes in Alberta’s First Nations Communities
  • Shainoor Virani
  • David Strong
  • Matthew Tennant
  • Mark Greve
  • Heather Young
  • Sandra Shade
  • Mebs Kanji
  • Ellen Toth
  • Implementation Committee of the Aboriginal Diabetes Initiative
Practice

Abstract

Objective: Identifying diabetes complications through screening using portable laboratory equipment in Aboriginal communities, and providing education and client empowerment for improved follow-up care and self-care.

Participants: First Nations people with known diabetes.

Setting: Screening was carried out in temporary clinics and laboratories set up at the local health centre in each of Alberta’s 44 First Nations.

Intervention: Two mobile units (“SLICK vans”), equipped with professionally trained staff, portable lab instruments and a retinal camera, travelled to all 44 Alberta First Nations communities to facilitate implementation of the Canadian Diabetes Association Clinical Practice Guidelines (CPGs). The project provided relevant education and counselling in conjunction with screening activities.

Outcomes: SLICK screened 1,151 clients between December 2001 and July 2003, and the project remains ongoing. A preliminary evaluation of the project’s 19-month implementation period showed screening activities and satisfaction with diabetes services were low prior to SLICK. There were modest improvements in some program outcomes at 6–12 months follow-up.

Conclusion: The SLICK project is designed to address the impact of diabetes by utilizing evidence-based CPGs with respect to screening for complications at the community level. It had a successful implementation period facilitated by community acceptance.

MeSH terms

Aboriginal North American type 2 diabetes mellitus diabetes-related complications screening mobile health units rural communities 

Résumé

Objectif: Cerner les complications du diabète dans les communautés autochtones en procédant à un dépistage dans des laboratoires mobiles, sensibiliser la clientèle, et renforcer son autonomie afin d’améliorer le suivi et les autosoins.

Participants: Les membres des Premières nations ayant reçu un diagnostique de diabète.

Lieu: Le dépistage s’est effectué dans des cliniques et des laboratoires temporaires mis sur pied dans le centre sanitaire local de chacune des 44 Premières nations de l’Alberta.

Intervention: Deux unités mobiles (les «minibus SLICK»), dotés d’un personnel qualifié, d’appareils de laboratoire portatifs et d’un rétinographe, se sont rendues dans les 44 communautés des Premières nations de l’Alberta pour faciliter la mise en oeuvre des lignes directrices de pratique clinique (LDPC) de l’Association canadienne du diabète. On a aussi offert des activités de sensibilisation et de counselling pour accompagner les activités de dépistage.

Résultats: Le projet SLICK a administré des tests de dépistage à 1 151 personnes entre décembre 2001 et juillet 2003, et ces activités se poursuivent. Une évaluation préliminaire des 19 premiers mois de mise en oeuvre a montré que les activités de dépistage et la satisfaction par rapport aux services offerts aux diabétiques étaient faibles avant le projet. Lors du suivi entre 6 et 12 mois, on a constaté de légères améliorations de certains résultats.

Conclusion: Le projet SLICK vise à atténuer l’impact du diabète en utilisant des LDPC fondées sur la recherche pour dépister les complications à l’échelle communautaire. La mise en oeuvre réussie du projet a été facilitée par son acceptation dans les communautés.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Statistics Canada. Canadian Community Health Survey, 2003. Statistics Canada, 2003.Google Scholar
  2. 2.
    Health Canada. Diabetes in Canada (2nd ed.). [article online], 2002. Available online at: http://www.phac-aspc.gc.ca/publicat/dic-dac2/pdf/dic-dac2_en.pdf (Accessed November 15, 2004).Google Scholar
  3. 3.
    Young TK, Mustard CA. Undiagnosed diabetes: Does it matter? JAMC 2001;164:26.Google Scholar
  4. 4.
    Ohinmaa A, Jacobs P, Simpson S, Johnson JA. The projection of prevalence and cost of diabetes in Canada: 2000 to 2016. Can J Diabetes 2004;28:1–8.Google Scholar
  5. 5.
    Chase LA. The trend of diabetes in Saskatchewan, 1905–1934. CMAJ 1937;36:366–69.Google Scholar
  6. 6.
    National Steering Committee for the First Nations and Inuit Regional Health Survey: Final report. [article online], 1999. Available online at: http://www.naho.ca/firstnations/english/pdf/key_doc_1.pdf (Accessed November 15, 2004).
  7. 7.
    Harris SB, Gittelsohn J, Hanley A, Barnie A, Wolever TM, Gao J, et al. The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care 1997;20:185–87.CrossRefGoogle Scholar
  8. 8.
    Fox C, Harris SB, Whalen-Brough E. Diabetes among Native Canadians in northwestern Ontario: 10 years later. Chron Dis Can 1994;15:92–96.Google Scholar
  9. 9.
    Pioro M, Dyck RF, Gillis DC. Diabetes prevalence rates among First Nations adults on Saskatchewan reserves in 1990: Comparison by tribal grouping, geography and with non-First Nation people. Can J Public Health 1996;87:325–28.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Dean HJ, Mundy RL, Moffatt M. Non-insulin-dependent diabetes mellitus in Indian children in Manitoba. CMAJ 1992;147:52–57.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Dean HJ, Young TK, Flett B, Wood-Steiman P. Screening for type-2 diabetes in Aboriginal children in northern Canada. Lancet 1998;352:523–24.Google Scholar
  12. 12.
    Dean HJ. NIDDM-Y in First Nations children in Canada. Clinical Pediatrics 1998;37:89–96.CrossRefGoogle Scholar
  13. 13.
    Harris SB, Perkins BA, Whalen-Brough E. Non-insulin-dependent diabetes mellitus among First Nations children. New entity among First Nations people of north western Ontario. Can Fam Phys 1996;42:869–76.Google Scholar
  14. 14.
    Sellers E, Dean HJ. INCIDENCE screening for type 2 diabetes mellitus in a high risk pediatric population: Capillary versus venous fasting glucose. Can J Diabetes 2004;28:309.Google Scholar
  15. 15.
    Gittelsohn J, Harris SB, Burris KL, Kakegamic L, Landman LT, Sharma A, et al. Use of ethnographic methods for applied research on diabetes among the Ojibway-Cree in northern Ontario. Health Educ Q 1996;23:365–82.CrossRefGoogle Scholar
  16. 16.
    Williams DE, Knowler WC, Smith CJ, Hanson RL, Roumain J, Saremi A, et al. The effect of Indian or Anglo dietary preference on the incidence of diabetes in Pima Indians. Diabetes Care 2001;24:811–16.CrossRefGoogle Scholar
  17. 17.
    Ravussin E, Valencia ME, Esparza J, Bennett PH, Schulz LO. Effects of a traditional lifestyle on obesity in Pima Indians. Diabetes Care 1994;17:1067–74.CrossRefGoogle Scholar
  18. 18.
    Young TK, Szathmary W, Carvers S, Wheatley B. Geographical distribution of diabetes among the Native population of Canada: A national survey. Soc Sci Med 1990;31:129–39.CrossRefGoogle Scholar
  19. 19.
    Hanson RL, Imperatore G, Venkat Narayan KM, Roumain J, Fagot-Campagna A, Pettitt DJ, et al. Family and genetic studies of indices of insulin sensitivity and insulin secretion in Pima Indians. Diabetes Metabolism Research Reviews 2001;17:296–303.CrossRefGoogle Scholar
  20. 20.
    Hegele RA, Cao H, Harris SB, Zinman B, Hanley AJ, Anderson CM. Gender, obesity, hepatic nuclear factor-1 alpha G219S and the age-of-onset of type 2 diabetes in Canadian Oji-Cree. Int J Obesity Related Metabolic Disorders 2000;24:1062–64.CrossRefGoogle Scholar
  21. 21.
    Lee ET, Howard BV, Savage PJ, Cowan LD, Fabsitz RR, Oopik AJ, et al. Diabetes and impaired glucose tolerance in three American Indian populations aged 45–74 years. The Strong Heart Study. Diabetes Care 1995;18:599–610.CrossRefGoogle Scholar
  22. 22.
    Health Canada. Just for You-Rural Canadians. [article online], 2002. Available online at: http://www.hc-sc.gc.ca/english/for_you/rural_canadians.html (Accessed November 15, 2004).Google Scholar
  23. 23.
    Macaulay AC, Montour LT, Adelson N. Prevalence of diabetic and atherosclerotic complications among Mohawk Indians of Kahnawake, PQ. CMAJ 1988;139:221–24.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Mao Y, Moloughney BW, Semenciw RM, Morrison HI. Indian Reserve and registered Indian mortality in Canada. Can J Public Health 1992;83:350–53.PubMedGoogle Scholar
  25. 25.
    Nathan DM. The pathophysiology of diabetic complications: How much does the glucose hypothesis explain? Ann Intern Med 1996;124:86–89.CrossRefGoogle Scholar
  26. 26.
    Brassard P, Robinson E. Factors associated with glycemia and microvascular complications among James Bay Cree Indian diabetics of Quebec. Arctic Med Res 1995;54:116–24.PubMedGoogle Scholar
  27. 27.
    Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, et al. and Diabetes Prevention Program Research Group. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.[see comment]. Ann Intern Med 2005;142:323–32.CrossRefGoogle Scholar
  28. 28.
    Ohkubo Y, Kishikawa H, Araki E. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103–17.CrossRefGoogle Scholar
  29. 29.
    UK Prospective Diabetes Study Group (UKPDS). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–53.CrossRefGoogle Scholar
  30. 30.
    UK Prospective Diabetes Study Group (UKPDS). Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854–65.CrossRefGoogle Scholar
  31. 31.
    Canadian Diabetes Association. Clinical Practice Guidelines 2003. Can J Diabetes 2003;27.Google Scholar
  32. 32.
    Krolewski AS, Warram JH, Freire MB. Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs. Endocrinology and Metabolism Clinics North America 2005;25:242.Google Scholar
  33. 33.
    Johnson JA, Maddigan S. Performance of the RAND-12 and SF-12 summary scores in type 2 diabetes. Quality of Life Res 2004;13:449–56.CrossRefGoogle Scholar
  34. 34.
    Michigan Diabetes Research and Training Centre. Diabetes History. [article online], 1998. Available online at: http://www.med.umich.edu/mdrtc/survey/index.html (Accessed August 26, 2005).Google Scholar
  35. 35.
    Michigan Diabetes Research and Training Centre. Brief Diabetes Knowledge Test. [article online], 1998. Available online at: http://www.med.umich.edu/mdrtc/survey/index.html (Accessed August 26, 2005).Google Scholar
  36. 36.
    Meltzer S, Leiter L, Daneman D, Gerstein HC, Lau D, Ludwig S, et al. Clinical practice guidelines for the management of diabetes in Canada. CMAJ 1998;159(Suppl. 8):S1–S29.Google Scholar
  37. 37.
    World Health Organization. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation on obesity. 2000. Available online at: http://whqlibdoc.who.int/trs/_WHO_TRS_894.pdf (Accessed November 15, 2004).Google Scholar
  38. 38.
    Despres J-P, Lemieux I, Prud’homme D. Treatment of obesity: Need to focus on high risk abdominally obese patients. BM J 2001;322:716–20.CrossRefGoogle Scholar
  39. 39.
    Rabkin SW, Chen Y, Leiter L, Liu L, Reeder BA. Risk factor correlates of body mass index. CMAJ 1997;157:S26–S31.PubMedGoogle Scholar
  40. 40.
    Reeder BA, Senthilselvan A, Despres J-P, Angel A, Liu L, Wang H, Rabkin SW. The association of cardiovascular disease risk factors with abdominal obesity in Canada. CMAJ 1997;157:S39–S45.PubMedGoogle Scholar
  41. 41.
    Lemley KV, Abdullah I, Myers BD, Meyer TW, Blouch K, Smith WE, et al. Evolution of incipient nephropathy in type 2 diabetes mellitus. Kidney International 2000;58:1228–37.CrossRefGoogle Scholar
  42. 42.
    World Health Organization (WHO) Expert Committee on Diabetes Mellitus: Second report. Geneva: WHO, 1980 (WHO Technical Report Series, No. 646;1–80).Google Scholar
  43. 43.
    Greenhalgh PM. Shared care for diabetes. A systematic review. Br J Gen Pract 1994;67:1–35.Google Scholar
  44. 44.
    Hoskins PL, Fowler PM, Constantino M, Forrest J, Yue DK, Turtle JR. Sharing the care of diabetic patients between hospital and general practitioners: Does it work? Diabetic Med 1993;10:81–86.CrossRefGoogle Scholar
  45. 45.
    Hurwitz B, Goodman C, Yudkin J. Prompting the clinical care of non-insulin dependent (type II) diabetic patients in an inner city area: One model of community care. BMJ 1993;306:624–30.CrossRefGoogle Scholar
  46. 46.
    Virani S, Datta NK. The SLICK Project: Screening for Limb, I-Eye, Cardiovascular, and Kidney Complications of Diabetes Using Mobile Diabetes Clinics. An Alberta First Nations Project. 2004.Google Scholar
  47. 47.
    Alberta Health and Wellness. Alberta Diabetes Strategy 2003–2013. [article online], 2003. Available online at: www.health.gov.ab.ca/public/diseases/pdf/Diabetes_Strategy.pdf (Accessed November 15, 2004).Google Scholar
  48. 48.
    Strategic Services AAAaND: First Nations of Alberta. Indian Population Register (Dec. 2003). [article online], 2004. Available online at: www.aand.gov.ab.ca/PDFs/FNPopFull_03.pdf (Accessed November 15, 2004).Google Scholar

Copyright information

© The Canadian Public Health Association 2006

Authors and Affiliations

  • Shainoor Virani
    • 1
  • David Strong
    • 1
  • Matthew Tennant
    • 2
  • Mark Greve
    • 2
  • Heather Young
    • 3
  • Sandra Shade
    • 3
  • Mebs Kanji
    • 4
  • Ellen Toth
    • 5
  • Implementation Committee of the Aboriginal Diabetes Initiative
  1. 1.Alberta Health and WellnessEdmontonCanada
  2. 2.Department of OphthalmologyUniversity of AlbertaEdmontonCanada
  3. 3.First Nations and Inuit Health Branch (FNIHB)Canada
  4. 4.Concordia UniversityMontrealCanada
  5. 5.Department of MedicineUniversity of AlbertaCanada

Personalised recommendations